TY - JOUR
T1 - Accuracy and reproducibility of the measurement of actively circulating blood volume with an integrated fiberoptic monitoring system
AU - Kisch, H.
AU - Leucht, S.
AU - Lichtwarck-Aschoff, M.
AU - Pfeiffer, U. J.
PY - 1995
Y1 - 1995
N2 - Objective: Bedside monitoring of circulating blood volume has become possible with the introduction of an integrated fiberoptic monitoring system that calculates blood volume from the changes in blood concentration of indocyanine green dye 4 mins after injection. The aim of this investigation was to compare the blood volume estimate of the integrated fiberoptic monitoring system (group 1) with the standard methods of blood volume measurement using Evans blue (group 2), and indocyanine green measured photometrically (group 3). Design: Prospective laboratory study. Setting: Animal laboratory of a University's institute for experimental surgery. Subjects: Eleven anesthetized, paralyzed, and mechanically ventilated piglets. Interventions: A central venous catheter was used for the injection of the indicator dyes (Evans blue and indocyanine green). A fiberoptic thermistor catheter was advanced into the thoracic aorta. The fiberoptic catheter detects indocyanine green by reflection densitometry for the estimation of blood volume of the integrated fiberoptic monitoring system. Samples for the determination of Evans blue and indocyanine green concentrations were drawn from an arterial catheter in the femoral artery over a period of 17 mins after injection. Measurements and Main Results: Measurements were performed during normovolemia, hypovolemia (blood withdrawal of ≤30 mL/kg), and hypervolemia (retransfusion of the withdrawn blood plus an infusion of 10% hydroxyethyl starch [45 mL/kg]). Linear regression, correlation, and bias were calculated for the comparison of the blood volume estimates by the fiberoptic monitoring system (group 1) vs. the total blood volume estimates using Evans blue (group 2) and indocyanine green (group 3); group 1 = 0.82 · group 2 - 26 mL; r2 = 82.71%; r = .91; n = 40; group 1 - group 2 ± 1 SD = -435 ± 368 mL; group 1 = 0.79 · group 3 + 50 mL; r2 = 74.81%; r = .87; n = 28; group 1 - group 3 ± 1 SD = -506 ± 374 mL. Conclusions: The results demonstrate that the blood volume estimate of the fiberoptic monitoring system (group 1) correlates closely with the total blood volume measurement using Evans blue (group 2) and indocyanine green (group 3). Trapped indicator in the packed red cell column after centrifugation of the blood samples may account for an overestimation of group 2 and group 3 of -10% to 14%, but there still remains a proportional difference of 10% between group 1 vs. group 2 and vs. group 3. This difference is due to the longer mixing times of group 3 (16 mins) and group 2 (17 mins), during which they are distributed in slowly exchanging blood pools. It seems that the blood volume estimate of the fiberoptic monitoring system (group 1) represents the actively circulating blood volume and may be useful for bedside monitoring.
AB - Objective: Bedside monitoring of circulating blood volume has become possible with the introduction of an integrated fiberoptic monitoring system that calculates blood volume from the changes in blood concentration of indocyanine green dye 4 mins after injection. The aim of this investigation was to compare the blood volume estimate of the integrated fiberoptic monitoring system (group 1) with the standard methods of blood volume measurement using Evans blue (group 2), and indocyanine green measured photometrically (group 3). Design: Prospective laboratory study. Setting: Animal laboratory of a University's institute for experimental surgery. Subjects: Eleven anesthetized, paralyzed, and mechanically ventilated piglets. Interventions: A central venous catheter was used for the injection of the indicator dyes (Evans blue and indocyanine green). A fiberoptic thermistor catheter was advanced into the thoracic aorta. The fiberoptic catheter detects indocyanine green by reflection densitometry for the estimation of blood volume of the integrated fiberoptic monitoring system. Samples for the determination of Evans blue and indocyanine green concentrations were drawn from an arterial catheter in the femoral artery over a period of 17 mins after injection. Measurements and Main Results: Measurements were performed during normovolemia, hypovolemia (blood withdrawal of ≤30 mL/kg), and hypervolemia (retransfusion of the withdrawn blood plus an infusion of 10% hydroxyethyl starch [45 mL/kg]). Linear regression, correlation, and bias were calculated for the comparison of the blood volume estimates by the fiberoptic monitoring system (group 1) vs. the total blood volume estimates using Evans blue (group 2) and indocyanine green (group 3); group 1 = 0.82 · group 2 - 26 mL; r2 = 82.71%; r = .91; n = 40; group 1 - group 2 ± 1 SD = -435 ± 368 mL; group 1 = 0.79 · group 3 + 50 mL; r2 = 74.81%; r = .87; n = 28; group 1 - group 3 ± 1 SD = -506 ± 374 mL. Conclusions: The results demonstrate that the blood volume estimate of the fiberoptic monitoring system (group 1) correlates closely with the total blood volume measurement using Evans blue (group 2) and indocyanine green (group 3). Trapped indicator in the packed red cell column after centrifugation of the blood samples may account for an overestimation of group 2 and group 3 of -10% to 14%, but there still remains a proportional difference of 10% between group 1 vs. group 2 and vs. group 3. This difference is due to the longer mixing times of group 3 (16 mins) and group 2 (17 mins), during which they are distributed in slowly exchanging blood pools. It seems that the blood volume estimate of the fiberoptic monitoring system (group 1) represents the actively circulating blood volume and may be useful for bedside monitoring.
KW - Evans blue
KW - blood volume
KW - catheter, fiberoptic
KW - critical care
KW - dye dilution technique
KW - hypovolemia
KW - indocyanine green
KW - monitoring, physiologic
KW - thermodilution
UR - http://www.scopus.com/inward/record.url?scp=0029077603&partnerID=8YFLogxK
U2 - 10.1097/00003246-199505000-00017
DO - 10.1097/00003246-199505000-00017
M3 - Article
C2 - 7736747
AN - SCOPUS:0029077603
SN - 0090-3493
VL - 23
SP - 885
EP - 893
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 5
ER -